Add to Favourites
To login click here
This report provides an analysis of the global automation in biopharma industry market, which was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033. Automation in biopharma is a way to incorporate advanced technologies and automated systems into the manufacturing process to improve efficiency, accuracy, and reliability. By utilizing biopharma automation, drug production can see improvements in both consistency and quality, as automated systems can perform tasks with a higher degree of accuracy than humans.
